No Data
No Data
Oppenheimer Sticks to Their Hold Rating for Cartesian Therapeutics (RNAC)
Buy Rating Affirmed for Cartesian Therapeutics Amid Clinical Success and Strengthened Financials
Express News | Needham Maintains Buy on Cartesian Therapeutics, Lowers Price Target to $41
Express News | Cartesian Therapeutics Inc : Needham Cuts Target Price to $41 From $42
Express News | Cartesian Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $45 From $49
Express News | Cartesian Therapeutics Cash, Cash Equivalents, And Restricted Cash Of $88.9M And Net Proceeds From $130M Pipe Financing Are Expected To Support Development Of Descartes-08 In Myasthenia Gravis; End-of-phase 2 Meeting With FDA Expected By Year-end
andy(三叔) : $Chicken Soup for the Soul Entertainment (CSSE.US)$ $Chicken Soup For The Soul Entmt Inc 9.50% Notes Due 2025 Usd25 (CSSEN.US)$ $Chicken Soup for the Soul Entertainment Inc (CSSEP.US)$
Trytosaveabit OP andy(三叔) : It’s a bankruptcy play from Redbox filing for protection!